Cybrexa, IsoPlexis add to management strength

Cybrexa Therapeutics, an oncology-focused biotechnology company based in New Haven, has appointed pharmaceutical and financial services veteran Stephen Basso to serve as its chief financial officer … more

IsoPlexis, a Branford-based life science technology company focused on proteomics, recently appointed Siddhartha Kadia to serve on its board of directors … more